ClinicalTrials.Veeva

Menu

Pancreas Screening in High Risk Individuals

University of British Columbia logo

University of British Columbia

Status

Not yet enrolling

Conditions

Pancreas Cancer Screening

Study type

Observational

Funder types

Other

Identifiers

NCT07012018
H25-01796

Details and patient eligibility

About

Pancreas cancer is the 11th most common cancer in Canada but the 4th most common cause of cancer death because by the time pancreas cancer is detected, it is almost always too advanced for surgery. There are known factors that put individuals at higher risk for pancreas cancer. These include: certain genetic mutations, a family history of pancreas cancer, pancreas cysts and a new diagnosis of diabetes mellitus. Individuals with these risk factors are recommended to undergo pancreas screening with blood tests and yearly imaging tests of the pancreas. Our study will enroll patients with these risk factors and ensure they are managed as per guidelines. Prospectively collected data will include: patient clinicodemographic details, lifestyle factors, screening test results, clinical outcomes and patient reported outcome measures.

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Family history of pancreatic cancer, pathogenic variant increasing risk of pancreatic cancer, IPMN, new onset diabetes.

Exclusion criteria

  • Unable to give informed consnet

Trial design

2,000 participants in 1 patient group

High risk individuals for pancreas cancer
Description:
Individuals undergoing pancreas screening

Trial contacts and locations

0

Loading...

Central trial contact

Jennifer Telford, MD MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems